FDA Discovers Contaminated Products, Unsterile Conditions at Ameridose
The report details a string of shortcomings, including ineffective drugs, unsterile or dilapidated environmental conditions and wildlife, at Ameridose. Sister company NECC is at the center of a federal investigation into a meningitis outbreak believed to be linked to contaminated NECC products. So far, the outbreak has claimed 32 lives and more than 400 meningitis illnesses.
Ameridose has already voluntarily recalled its products in late October after the FDA reported the company could not demonstrate product sterility and safety.
More Articles on Patient Safety:4 Risk Factors for Immediate Use Sterilization
© Copyright ASC COMMUNICATIONS 2017. Interested in LINKING to or REPRINTING this content? View our policies by clicking here.
To receive the latest hospital and health system business and legal news and analysis from Becker's Hospital Review, sign-up for the free Becker's Hospital Review E-weekly by clicking here.
- How the 21st Century Cures Act impacts ASC physicians — 2 ASCA leaders shed insight
- 4 interventional spine pain procedures see 16%+ lower payment in 2017 — could the downward trend reverse next year?
- Total hip arthroplasty same-day vs. next-day discharge: 6 key findings
- 7 things for ASC leaders to know for Thursday — Feb. 23, 2017
- NAPA to present at 2017 AACD Perioperative Leadership Summit